Placental transfer of maternal poliovirus antibodies in full-term and pre-term infants. 1998

N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
Department of Neonatology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

This study was designed to investigate the placental transfer of maternal poliovirus antibodies in full-term and pre-term infants. Two hundred healthy, Israeli born mothers and their infants, were enrolled immediately after birth. The study population comprised two groups: a full-term group of 150 mothers and their infants, and a pre-term group of 50 mothers and their infants (gestational age < 35 weeks). Maternal and umbilical cord blood samples were taken in all cases. Antibody titers against the three poliovirus serotypes and a polio virus type 1 strain that caused an outbreak in 1988 (epidemic strain 1) were measured by a microneutralization system. The proportion of individuals with protective titers against each of the poliovirus types tested was slightly lower in the infants compared with their mothers. When protection to all strains combined was tested, the difference between mothers and infants was significant (P < 0.05). Transplacental transfer to epidemic strain 1 was less effective--12% of the premature infants were not protected against it at birth. The geometric mean titers against poliovirus types 1, 3 and epidemic type 1 strain were significantly lower in the pre-term group than in the full-term group. In both the full-term and pre-term groups there were significant linear correlations between the maternal and neonatal antibody titers for each of the polio viruses tested. For all poliovirus types, the transfer of maternal antibodies to the full-term infant was significantly higher than the transfer of maternal antibodies to the pre-term infant (P < 0.001). Owing to diminished transfer of maternal antibodies, pre-term infants are at greater risk of poliovirus infection.

UI MeSH Term Description Entries
D007112 Immunity, Maternally-Acquired Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Fetal Immunity, Maternally-Acquired,Maternally-Acquired Immunity,Neonatal Immunity, Maternally-Acquired,Immunity, Maternally Acquired,Fetal Immunities, Maternally-Acquired,Fetal Immunity, Maternally Acquired,Immunity, Maternally-Acquired Fetal,Immunity, Maternally-Acquired Neonatal,Maternally Acquired Immunities,Maternally Acquired Immunity,Maternally-Acquired Fetal Immunities,Maternally-Acquired Fetal Immunity,Maternally-Acquired Immunities,Maternally-Acquired Neonatal Immunities,Maternally-Acquired Neonatal Immunity,Neonatal Immunities, Maternally-Acquired,Neonatal Immunity, Maternally Acquired
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D008297 Male Males
D005260 Female Females
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D017955 Poliovirus A species of ENTEROVIRUS which is the causal agent of POLIOMYELITIS in humans. Three serotypes (strains) exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection. Brunhilde Virus,Human poliovirus 1,Human poliovirus 2,Human poliovirus 3,Lansing Virus,Leon Virus,Poliovirus Type 1,Poliovirus Type 2,Poliovirus Type 3,Polioviruses

Related Publications

N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
January 1999, Infection,
N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
February 1997, The Pediatric infectious disease journal,
N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
March 2024, iScience,
N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
February 2003, Journal of medical virology,
N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
January 2006, Pediatric nephrology (Berlin, Germany),
N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
January 1983, Acta paediatrica Scandinavica. Supplement,
N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
July 2015, JAMA pediatrics,
N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
November 1984, Acta paediatrica Scandinavica,
N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
August 2020, BMC infectious diseases,
N Linder, and I Taushtein, and R Handsher, and G Ohel, and B Reichman, and A Barzilai, and J Kuint, and N Davidovitch, and E Mendelson, and R Dagan
December 1990, Archives francaises de pediatrie,
Copied contents to your clipboard!